Evidence map›Paper›PMID 17517876›Full record

ArticleInfection and immunity2007

Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis.

W Joost Wiersinga, Catharina W Wieland, Gerritje J W van der Windt, Anita de Boer, Sandrine Florquin, Arjen Dondorp, Nicholas P Day, Sharon J Peacock, Tom van der Poll

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Single-stranded DNA oligonucleotides containing CpG motifs are non-stimulatoryFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Melioidosis.Nature reviews. Disease primers · 2018
    Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Development of Burkholderia mallei and pseudomallei vaccines.Frontiers in cellular and infection microbiology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

W Joost WiersingaAcademic Medical Center, Meibergdreef 9, Room G2-132, 1105 AZ Amsterdam, The Netherlands. w.j.wiersinga@amc.uva.nl
Catharina W Wieland
Gerritje J W van der Windt
Anita de Boer
Sandrine Florquin
Arjen Dondorp
Nicholas P Day
Sharon J Peacock
Tom van der Poll
Center for Molecular Medicine and Immunology · USInstitute of Infection and Immunity · CAAcademic Medical Center · NLMahidol Oxford Tropical Medicine Research Unit · THMahidol University · THNuffield Orthopaedic Centre · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Melioidosis is caused by the soil saprophyte Burkholderia pseudomallei and is endemic in Southeast Asia. The pathogenesis of melioidosis is still largely unknown, although gamma interferon (IFN-gamma) seems to play an obligatory role in host defense. Previously, we have shown that IFN-gamma production in melioidosis is controlled in part by interleukin-18 (IL-18). The aim of the present study was to determine the role of IL-18 in the immune response to B. pseudomallei. For this the following investigations were performed. (i) Plasma IL-18 and blood monocyte IL-18 mRNA levels were elevated in 34 patients with culture-proven melioidosis compared to the levels in 32 local healthy controls; in addition, IL-18 binding protein levels were markedly elevated in patients, strongly correlating with mortality. (ii) IL-18 gene-deficient (IL-18 knockout [KO]) mice showed accelerated mortality after intranasal infection with a lethal dose of B. pseudomallei, which was accompanied by enhanced bacterial growth in their lungs, livers, spleens, kidneys, and blood at 24 and 48 h postinfection, compared to wild-type mice. In addition, IL-18 KO mice displayed evidence of enhanced hepatocellular injury and renal insufficiency. Together, these data indicate that the enhanced production of IL-18 in melioidosis is an essential part of a protective immune response to this severe infection.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsBloodBurkholderia pseudomalleiColony Count, MicrobialDisease Models, AnimalFemaleHistocytochemistryHumansIntercellular Signaling Peptides and ProteinsInterleukin-18KidneyLiverIntercellular Signaling Peptides and ProteinsInterleukin-18interleukin-18 binding proteinRNA, Messenger

Identifiers

PMID17517876
PMCPMC1951987
OpenAlexW2114899858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.